Bisoprolol responses (PK/PD) in hypertensive patients: A cytochrome P450 (CYP) 2D6 targeted polymorphism study

por Mohammed Alkreathy, Huda, Mohammed Eid Alsayyid, Khlood, Alaama, Jumana Y., Al Ghalayini, Kamal, Karim, Shahid, Esmat, Ahmed, Damanhouri, Zoheir A.
Publicado 2020

Saudi Heart Association Position Statement on the Use of Biomarkers for the Management of Heart Failure and Acute Coronary Syndrome

por AlHabeeb, Waleed, Tash, Adel Abdulkader, Almutari, Fawaz, Al Ghalayini, Kamal, Alqaseer, Maryam, Alshamiri, Mostafa, Kharabsheh, Suleiman, AlKashkari, Wail
Publicado 2022

Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey

por Abdelhamid, Magdy, Al Ghalayini, Kamal, Al‐Humood, Khaldoon, Altun, Bülent, Arafah, Mohammed, Bader, Feras, Ibrahim, Mohamed, Sabbour, Hani, Shawky Elserafy, Ahmed, Skouri, Hadi, Yilmaz, Mehmet Birhan
Publicado 2023

Prevalence of Diabetes and Hypertension Among King Abdulaziz University Employees: Data From First Aid and Cardiopulmonary Resuscitation Training Program

por Khafaji, Mawya A, Al Ghalayini, Kamal W, Sait, Maram K, Alorri, Rafal A, Garoub, Tasneem, Alharbi, Esrra A, Magadmi, Talah, Fatani, Falwah, Jan, Hussain F, Jawhari, Abdulkarim A
Publicado 2021

Strategic Recommendations to Bridge the Gaps in Awareness, Diagnosis and Prevention of Heart Failure in the Middle East Region and Africa

por Bennis, Ahmed, Ogola, Elijah N., Klug, Eric, Skouri, Hadi N., Al Saffar, Hilal Bahjet, Ragy, Hany, AlGhalayini, Kamal Waheeb, Alhumood, Khaldoon A., Abdelhamid, Magdy, Yilmaz, Mehmet Birhan, Tabbalat, Ramzi, Çavuşoğlu, Yüksel
Publicado 2022

Saudi Heart Association (SHA) guidelines for the management of heart failure

por AlHabeeb, Waleed, Al-Ayoubi, Fakhr, AlGhalayini, Kamal, Al Ghofaili, Fahad, Al Hebaishi, Yahya, Al-Jazairi, Abdulrazaq, Al-Mallah, Mouaz H., AlMasood, Ali, Al Qaseer, Maryam, Al-Saif, Shukri, Chaudhary, Ammar, Elasfar, Abdelfatah, Tash, Adel, Arafa, Mohamed, Hassan, Walid
Publicado 2019